Arrowhead Pharmaceuticals
ARWR
#3933
Rank
S$3.28 B
Marketcap
$26.36
Share price
-0.26%
Change (1 day)
-34.45%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): -$2.37

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.30. In 2022 the company made an earnings per share (EPS) of -$1.98 an increase over its 2021 EPS that were of -$2.39.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.3719.94%
2022-$1.98-17.05%
2021-$2.3974.26%
2020-$1.37-283.64%
2019$0.75-257.14%
2018-$0.47-27.08%
2017-$0.65-59.32%
2016-$1.60-21.85%
2015-$2.059.42%
2014-$1.872.87%
2013-$1.82-31.56%
2012-$2.66300%
2011-$0.66-45.56%
2010-$1.22-66.67%
2009-$3.66-63.51%
2008-$10.03-12.94%
2007-$11.5244.07%
2006-$8.0077.35%
2005-$4.5110.66%
2004-$4.07-54.25%
2003-$8.91-80.51%
2002-$45.703.87%
2001-$43.99116.17%
2000-$20.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.57 141.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.13-192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.88-61.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.09-928.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.39 437.65%๐Ÿ‡บ๐Ÿ‡ธ USA